On the evening of June 14, the Hong Kong Stock Exchange-listed company Smoore International (06969.HK) issued a statement. It stated that on June 21, 2024, one of the group's clients, NJOY LLC (a wholly-owned subsidiary of Altria Group), has received marketing authorization orders (MGO) for four new tobacco products (including two menthol-flavored closed pod electronic cigarettes (NJOY ACE Pod Menthol 2.4%, NJOY ACE Pod Menthol 5%) and two menthol-flavored disposable e-cigarettes (NJOY DAILY Menthol 4.5%, NJOY DAILY EXTRA Menthol 6%)) through the pre-market tobacco product application (PMTA) pathway.
Smoore International announced that as of the date of this announcement, the company's client NJOY LLC has received marketing approvals for ten new tobacco products through the pre-market pathway, including a NJOY ACE closed-system e-cigarette device, five NJOY ACE tobacco and menthol flavored closed-system electronic pods, and four NJOY DAILY tobacco and menthol flavored disposable e-cigarettes. Based on sales records from the beginning of the year to the date of this announcement, the company has supplied these ten products to NJOY LLC.
It is worth noting that on the first trading day after the FDA announcement, Smoore International opened higher in early trading and surged over 12% at one point. As of the time of writing, the stock is currently trading at 10.04 Hong Kong dollars.
Notice
1. This article is provided exclusively for professional research purposes related to industry, technology and policy. Any reference to brands or products is made solely for the purpose of objective description and does not constitute an endorsement, recommendation, or promotion of any brand or product.
2. The use of nicotine products, including but not limited to cigarettes, e-cigarettes, and heated tobacco products, is associated with significant health risks. Users are required to comply with all relevant laws and regulations in their respective jurisdictions.
3. This article is strictly restricted from being accessed or viewed by individuals under the legal age.
Copyright
This article is either an original work by 2Firsts or a reproduction from third-party sources with the original source clearly indicated. The copyright and usage rights of this article belong to 2Firsts or the original source. Unauthorized reproduction, distribution, or any other unauthorized use of this article by any entity or individual is strictly prohibited. Violators will be held legally responsible. For copyright-related matters, please contact: info@2firsts.com
AI Assistance Disclaimer
This article may have utilized AI to enhance translation and editing efficiency. However, due to technical limitations, errors may occur. Readers are advised to refer to the sources provided for more accurate information.
This article should not be used as a basis for any investment decisions or advice, and 2Firsts assumes no direct or indirect liability for any errors in the content.
